Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 19,765 full-time employees. The company went IPO on 2005-09-28. The firm is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The firm is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
Follow-Up Questions
Who is the CEO of Daiichi Sankyo Co Ltd?
Mr. Sunao Manabe is the Chairman of the Board of Daiichi Sankyo Co Ltd, joining the firm since 2012.
What is the price performance of DSKYF stock?
The current price of DSKYF is $25.11, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Daiichi Sankyo Co Ltd?
Daiichi Sankyo Co Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is Daiichi Sankyo Co Ltd market cap?
Daiichi Sankyo Co Ltd's current market cap is $47.5B
Is Daiichi Sankyo Co Ltd a buy, sell, or hold?
According to wall street analysts, 20 analysts have made analyst ratings for Daiichi Sankyo Co Ltd, including 8 strong buy, 12 buy, 1 hold, 0 sell, and 8 strong sell
